In 2025, four companies with Cornell-originated technologies — SafetyStratus, Bactana Corporation, Guard Medical and Halo Labs — were acquired by global corporate partners, allowing Cornell technologies to reach broader markets.
Dr. Despina Siolas, assistant professor of medicine at Weill Cornell Medicine and an oncologist at NewYork-Presbyterian/Weill Cornell Medical Center, is working on personalizing treatment for pancreatic cancer, which is often diagnosed too late.
To equip astronauts with health choices for future missions, a Cornell postdoctoral fellow is leading research with AstroCup, a group that recently tested two menstrual cups in spaceflight as payload on an uncrewed rocket flight.
Chemotherapy activates a stress sensor in immune cells, which may help explain why many cancer patients experience debilitating pain as a side effect, according to Weill Cornell Medicine and Wake Forest University researchers.
